Publications by authors named "Jean de Vry"

Claim this Profile
S
Synergistic interaction between the agonism of cebranopadol at nociceptin/orphanin FQ and classical opioid receptors in the rat spinal nerve ligation model.
Thomas Christoph, Robert Raffa, Jean De Vry, Wolfgang Schröder

Pharmacol Res Perspect· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist.
Klaus Linz, Thomas Christoph, Thomas M Tzschentke, Thomas Koch, Klaus Schiene, Jean De Vry

J Pharmacol Exp Ther· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spinal-supraspinal and intrinsic μ-opioid receptor agonist-norepinephrine reuptake inhibitor (MOR-NRI) synergy of tapentadol in diabetic heat hyperalgesia in mice.
Thomas Christoph, Wolfgang Schröder, Ronald J Tallarida, Jean De Vry, Thomas M Tzschentke

J Pharmacol Exp Ther· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological and behavioral profile of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-6-chinolincarboxamide (EVP-5141), a novel α7 nicotinic acetylcholine receptor agonist/serotonin 5-HT3 receptor antagonist.
Frank G Boess, Jean de Vry, Christina Erb, Timo Flessner, Martin Hendrix

Psychopharmacology (Berl)· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tapentadol increases levels of noradrenaline in the rat spinal cord as measured by in vivo microdialysis.
Thomas M Tzschentke, Joost H A Folgering, Gunnar Flik, Jean De Vry

Neurosci Lett· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antinociceptive and antihyperalgesic effects of tapentadol in animal models of inflammatory pain.
Klaus Schiene, Jean De Vry, Thomas M Tzschentke

J Pharmacol Exp Ther· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical evaluation of the use of extinction paradigms for the assessment of opioid-induced conditioned place preference in rats.
Kris Rutten, Elizabeth L van der Kam, Jean De Vry, Thomas M Tzschentke

Pharmacology· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic antihypersensitive effects of pregabalin and tapentadol in a rat model of neuropathic pain.
Thomas Christoph, Jean De Vry, Klaus Schiene, Ronald J Tallarida, Thomas M Tzschentke

Eur J Pharmacol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological blockade or genetic knockout of the NOP receptor potentiates the rewarding effect of morphine in rats.
Kris Rutten, Jean De Vry, Walter Bruckmann, Thomas M Tzschentke

Drug Alcohol Depend· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissociation of rewarding, anti-aversive and anti-nociceptive effects of different classes of anti-nociceptives in the rat.
Kris Rutten, Jean De Vry, Angela Robens, Thomas M Tzschentke, Elizabeth L van der Kam

Eur J Pain· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The antinociceptive and antihyperalgesic effect of tapentadol is partially retained in OPRM1 (μ-opioid receptor) knockout mice.
Babette Kögel, Jean De Vry, Thomas M Tzschentke, Thomas Christoph

Neurosci Lett· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates conditioned place preference induced by various addictive and non-addictive drugs in rats.
Kris Rutten, Elizabeth L Van Der Kam, Jean De Vry, Walter Bruckmann, Thomas M Tzschentke

Addict Biol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the NOP receptor agonist Ro65-6570 on the acquisition of opiate- and psychostimulant-induced conditioned place preference in rats.
Kris Rutten, Jean De Vry, Walter Bruckmann, Thomas M Tzschentke

Eur J Pharmacol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential contribution of opioid and noradrenergic mechanisms of tapentadol in rat models of nociceptive and neuropathic pain.
Wolfgang Schröder, Jean De Vry, Thomas M Tzschentke, Ulrich Jahnel, Thomas Christoph

Eur J Pain· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain.
Thomas Christoph, Jean De Vry, Thomas M Tzschentke

Neurosci Lett· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tapentadol hydrochloride: a next-generation, centrally acting analgesic with two mechanisms of action in a single molecule.
Thomas M Tzschentke, Ulrich Jahnel, Babette Kogel, Thomas Christoph, Werner Englberger, Jean De Vry

Drugs Today (Barc)· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mGlu5 receptor antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) supports intravenous self-administration and induces conditioned place preference in the rat.
Elizabeth L van der Kam, Jean De Vry, Thomas M Tzschentke

Eur J Pharmacol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates ketamine and heroin reward as assessed by acquisition, extinction, and reinstatement of conditioned place preference in the rat.
Elizabeth L van der Kam, Jean De Vry, Thomas M Tzschentke

Eur J Pharmacol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of morphine on the affective and the sensory component of carrageenan-induced nociception in the rat.
Elizabeth Louise van der Kam, Jean De Vry, Klaus Schiene, Thomas Michael Tzschentke

Pain· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of TRPV1 loss-of-function phenotypes in transgenic shRNA expressing and knockout mice.
Thomas Christoph, Gregor Bahrenberg, Jean De Vry, Werner Englberger, Volker A Erdmann

Mol Cell Neurosci· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of 2-methyl-6-(phenylethynyl) pyridine on intravenous self-administration of ketamine and heroin in the rat.
Elizabeth L van der Kam, Jean de Vry, Thomas M Tzschentke

Behav Pharmacol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties.
Thomas M Tzschentke, Thomas Christoph, Babette Kögel, Klaus Schiene, Hagen-Heinrich Hennies, Jean De Vry

J Pharmacol Exp Ther· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents.
Frank G Boess, Jean De Vry, Christina Erb, Timo Flessner, Martin Hendrix

J Pharmacol Exp Ther· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of venlafaxine and desipramine on heroin-induced conditioned place preference in the rat.
Thomas M Tzschentke, Zofia Magalas, Jean De Vry

Addict Biol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The serotonin/noradrenaline reuptake inhibitor venlafaxine attenuates acquisition, but not maintenance, of intravenous self-administration of heroin in rats.
Zofia Magalas, Jean De Vry, Thomas M Tzschentke

Eur J Pharmacol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis